Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Endocrine
|
November 8, 2021
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives
Michele Klain, Julien Hadoux, Carmela Nappi, et al.
FEBS Letters
|
March 27, 2004
Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation
Stefania Crispi, Emma Sanzari, Jlenia Monfregola, et al.
Endocrine-Related Cancer
|
January 24, 2023
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors
Tommaso Porcelli, Raffaele Ambrosio, Maria Angela De Stefano, et al.
Gene
|
June 1, 2002
The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter
Raffaele Ambrosio, Giorgia Fimiani, Jlenia Monfregola, et al.
Gastroenterology
|
July 10, 2012
β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells
Monica Dentice, Cristina Luongo, Raffaele Ambrosio, et al.
The Journal of Clinical Investigation
|
March 5, 2026
Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewal
Maria Angela De Stefano, Raffaele Ambrosio, Cristina Luongo, et al.
Nucleic Acids Research
|
January 9, 2015
A composite enhancer regulates p63 gene expression in epidermal morphogenesis and in keratinocyte differentiation by multiple mechanisms
Dario Antonini, Anna Sirico, Edith Aberdam, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Maria Grazia Castagna, Monica Dentice, Silvia Cantara, et al.
Cancers
|
October 13, 2021
Advances in Functional Imaging of Differentiated Thyroid Cancer
Michele Klain, Emilia Zampella, Carmela Nappi, et al.
JCO Precision Oncology
|
August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Endocrine
|
November 8, 2021
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives
Michele Klain, Julien Hadoux, Carmela Nappi, et al.
FEBS Letters
|
March 27, 2004
Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation
Stefania Crispi, Emma Sanzari, Jlenia Monfregola, et al.
Endocrine-Related Cancer
|
January 24, 2023
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors
Tommaso Porcelli, Raffaele Ambrosio, Maria Angela De Stefano, et al.
Gene
|
June 1, 2002
The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter
Raffaele Ambrosio, Giorgia Fimiani, Jlenia Monfregola, et al.
Gastroenterology
|
July 10, 2012
β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells
Monica Dentice, Cristina Luongo, Raffaele Ambrosio, et al.
The Journal of Clinical Investigation
|
March 5, 2026
Type 2 deiodinase-dependent surge in thyroid hormone controls muscle stem cell quiescence and self-renewal
Maria Angela De Stefano, Raffaele Ambrosio, Cristina Luongo, et al.
Nucleic Acids Research
|
January 9, 2015
A composite enhancer regulates p63 gene expression in epidermal morphogenesis and in keratinocyte differentiation by multiple mechanisms
Dario Antonini, Anna Sirico, Edith Aberdam, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Maria Grazia Castagna, Monica Dentice, Silvia Cantara, et al.
Cancers
|
October 13, 2021
Advances in Functional Imaging of Differentiated Thyroid Cancer
Michele Klain, Emilia Zampella, Carmela Nappi, et al.
JCO Precision Oncology
|
August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Page
of 4